1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the...
When investors think of biotech stocks, visions of Amgen (AMGN) and Gilead (
What can the wagon tracks carved by 1800s American pioneers teach us about modern day investing? Karlin Conklin explains the key to 'striking gold' in commercial real estate.
More Investing News »